Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Applying the genome to national drug formulary policy in the developing world.

Pharmacogenomics - 1 May 2010

Roederer Mary W, McLeod Howard L

Abstract excerpt

With pharmacogenetics comes the promise of individualized therapy selection for many common diseases where multiple treatment options are available. Recent advances including the Human Genome Project, the International HapMap project, advances in throughput technology and reduction in cost of genetic testing, and the inclusion of genotype-related dosing recommendations into package inserts all point to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Delivery of Health Care
Share to Genome
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Human Genome Project

Share to Pharmacogenetics

Share to Population Groups

Share to Public Policy

Source

Identifiers

PMID: 20415551
DOI: 10.2217/pgs.10.55

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Applying the genome to national drug formulary policy in the developing world.PMID 20415551Read ↗

Relevance of pharmacogenomics for developing countries in EuropeSemantic proximity Read ↗

Planning for a national effort to enable and accelerate discoveries in pharmacogenetics: the NIH Pharmacogenetics Research Network.Semantic proximity Read ↗

Pharmacogenetics: An Important Part of Drug Development with A Focus on Its ApplicationSemantic proximity Read ↗

One Step Ahead in Realizing Pharmacogenetics in Low- and Middle-Income Countries: What Should We Do?Semantic proximity Read ↗

Pharmacogenomics: historical perspective and current status.Semantic proximity Read ↗

A SNPshot: pharmacogenetics and the future of drug therapy.Semantic proximity Read ↗

Genome-based pharmacogenetics and the pharmaceutical industry.Semantic proximity Read ↗

Pharmacogenetics in clinical practice: how far have we come and where are we going?Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: development, science, and translation.Semantic proximity Read ↗

Pharmacogenetics: from discovery to patient care.Semantic proximity Read ↗

Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.Semantic proximity Read ↗

Pharmacogenomics and patient care: one size does not fit all.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.